A 60-year-year-old man with long-term PPI therapy develops hip fragility fracture. Which additional measure is recommended alongside osteoporosis mana...

Question

A 60-year-year-old man with long-term PPI therapy develops hip fragility fracture. Which additional measure is recommended alongside osteoporosis management?

Accepted Answer

Assess calcium/vitamin D and bone protection; review ongoing PPI need

Answer

Stop all PPIs immediately

Answer

Start H2 blocker automatically

Answer

No change

Answer

Start calcitonin

ukmla MCQ (SBA): PPI Review & Bone Health

A 60-year-year-old man with long-term PPI therapy develops hip fragility fracture. Which additional measure is recommended alongside osteoporosis management?